Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2026-02-20 @ 8:27 PM
Study NCT ID:
NCT02099292
Status:
COMPLETED
Last Update Posted:
2014-03-28
First Post:
2014-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma
Sponsor:
Georg Hess, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Mainz-135
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None